Plaintiff in this medical malpractice case was not entitled to peer review documents regarding the outcome of a specific medical procedure, but the court permitted limited discovery involving a defendant facility's credentialing of a doctor.

Although board member was placed on conflicts committee prior to merger when the member did not meet qualifications under the company's partnership agreement, the evidence was insufficient to find that the merger was unfair or unreasonable to the company or its limited partners, and the lack of evidence of bad faith or willful misconduct also triggered application of an exculpation from money damages.

Superior court did not abuse discretion in denying motion to vacate dismissal based on after-decided federal cases where differences between the federal first-filed rule and Delaware's first-filed rule meant the superior court could handle plaintiffs' second-filed action differently than it might be handled under the federal rule.

Arbitrary company valuation used to calculate share exchange in merger transaction did not constitute adequate evidence to support damages for a breach of contract claim.

The Delaware Supreme Court rejected the continuous negligent medical treatment doctrine in this case, and remanded for factual findings involving the statute of limitations.